← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Agah Ramtin
Officer
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001862617
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 6
- Purchases · 24M
- 11
- Average purchase
- $14.6K
- Median purchase
- $13.5K
- Gross purchase value
- $161.0K
Companies: RenovoRx, Inc.
11 SEC accession(s) · 0 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-01-22 | RenovoRx, Inc. | RNXT | Officer | $10.0K | Open filing |
| 2026-01-05 | RenovoRx, Inc. | RNXT | Officer | $8.4K | Open filing |
| 2026-01-02 | RenovoRx, Inc. | RNXT | Officer | $170 | Open filing |
| 2025-12-17 | RenovoRx, Inc. | RNXT | Officer | $10.2K | Open filing |
| 2025-12-08 | RenovoRx, Inc. | RNXT | Officer | $9.6K | Open filing |
| 2025-11-24 | RenovoRx, Inc. | RNXT | Officer | $17.6K | Open filing |
| 2025-06-09 | RenovoRx, Inc. | RNXT | Officer | $29.4K | Open filing |
| 2025-04-17 | RenovoRx, Inc. | RNXT | Officer | $13.5K | Open filing |
| 2025-04-14 | RenovoRx, Inc. | RNXT | Officer | $16.0K | Open filing |
| 2025-04-10 | RenovoRx, Inc. | RNXT | Officer | $24.3K | Open filing |
| 2025-04-09 | RenovoRx, Inc. | RNXT | Officer | $21.8K | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
No completed point-in-time price outcome is available yet.
Research patterns
- First purchase in 12M
- 0/10
- Large purchase ≥ $100k
- 0/11
- Cluster buying · 15D
- 6/11
- Buying the dip
- 0/—
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.